COMMANDER
Oral Rivaroxaban vs placebo for the prevention of CV events in chronic congestive HF subjects with significant obstructive CAD
- Stadium
- klaar
- Middel
- rivaroxaban
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 15 november 2013
- Last Patient In
- 27 juli 2017
- Last Patient Last Visit
- 14 mei 2018
Studiedirecteur
